Blueprint Medicines Corp. (BPMC)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.003% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Torray Funds | Add 0.44% | 71 | 0.00 | |
| Q1 2024 | |||||
| ≡ | Torray Funds | Add 0.96% | 185 | 0.00 | |
| Q3 2023 | |||||
| ≡ | Torray Funds | Add 4.43% | 1,051 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Torray Funds | Add 0.58% | 137 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Torray Funds | Add 0.71% | 167 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Torray Funds | Add 34.02% | 5,949 | 0.05 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Add 15.32% | 2,323 | 0.03 | |
| Q2 2022 | |||||
| ≡ | Torray Funds | Add 21.42% | 2,675 | 0.03 | |
| Q1 2022 | |||||
| ≡ | Torray Funds | Add 7.94% | 919 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Torray Funds | Add 34.51% | 4,089 | 0.06 | |
| Q2 2021 | |||||
| ≡ | Torray Funds | Add 2.98% | 343 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Torray Funds | Buy | 11,506 | 0.18 | |
| Q4 2020 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 2,709,138 | 1.10 | |
| Q2 2020 | |||||
| ≡ | Viking Global Investors | Add 1.83% | 29,249 | 0.01 | |
| Q1 2020 | |||||
| ≡ | Viking Global Investors | Add 22.50% | 293,926 | 0.09 | |
| Q4 2019 | |||||
| ≡ | Viking Global Investors | Add 62.98% | 504,902 | 0.19 | |
| Q3 2019 | |||||
| ≡ | Viking Global Investors | Add 45.48% | 250,599 | 0.10 | |
| Q4 2017 | |||||
| ≡ | Leon Cooperman | Buy | 75,000 | 0.21 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.